Charles Schwab
TSVT

Charles Schwab’s 2seventy bio TSVT Stock Holding History

Charles Schwab’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-417,950
Closed -$2.06M – 3575
2025
Q1 		$2.06M Sell
417,950
-10,710
-2% -$34K ﹤0.01% 2608
2024
Q4 		$1.26M Buy
428,660
+15,061
+4% +$61.8K ﹤0.01% 2829
2024
Q3 		$1.95M Sell
413,599
-35,679
-8% -$161K ﹤0.01% 2710
2024
Q2 		$1.73M Sell
449,278
-165,247
-27% -$745K ﹤0.01% 2748
2024
Q1 		$3.29M Sell
614,525
-4,790
-0.8% -$22.5K ﹤0.01% 2444
2023
Q4 		$2.64M Buy
619,315
+74,413
+14% +$229K ﹤0.01% 2531
2023
Q3 		$2.14M Buy
544,902
+127,073
+30% +$833K ﹤0.01% 2576
2023
Q2 		$4.23M Buy
417,829
+97,836
+31% +$1.04M ﹤0.01% 2297
2023
Q1 		$3.26M Sell
319,993
-1,586
-0.5% -$18.1K ﹤0.01% 2380
2022
Q4 		$3.01M Buy
321,579
+6,868
+2% +$96.9K ﹤0.01% 2435
2022
Q3 		$4.58M Buy
314,711
+45,894
+17% +$681K ﹤0.01% 2259
2022
Q2 		$3.55M Buy
268,817
+98,686
+58% +$1.34M ﹤0.01% 2344
2022
Q1 		$2.9M Buy
170,131
+6,143
+4% +$104K ﹤0.01% 2516
2021
Q4 		$4.2M Buy
+163,988
New +$5.11M ﹤0.01% 2436

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Charles Schwab's TSVT Position: Q2 2025 in Review

Charles Schwab sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 417,950 shares — an estimated $2.06M sold.

Charles Schwab first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $4.58M in Q3 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Charles Schwab reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Charles Schwab sold 417,950 2seventy bio shares in Q2 2025, an estimated $2.06M.
  • Charles Schwab first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Charles Schwab's 2seventy bio position peaked at $4.58M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.